This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Intervacc Ab. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Kenneth Janzon: Innovator in Antigenic Composition
Introduction
Kenneth Janzon is a notable inventor based in Hagersten, Sweden. He has made significant contributions to the field of immunization through his innovative work on antigenic compositions. His research focuses on developing vaccines that can effectively immunize non-human mammals against specific pathogens.
Latest Patents
Kenneth Janzon holds 1 patent related to an antigenic composition. This invention comprises at least one antigen that includes antigenic epitopes or determinants derived from proteins present in specific subspecies. The patent also discloses a vaccine composition that utilizes this antigenic composition as an immunizing component. The antigens involved in this invention are EAG, FNZ, SFS, SEC, and ScLC.
Career Highlights
Throughout his career, Kenneth has demonstrated a commitment to advancing vaccine technology. His work has the potential to improve immunization strategies for non-human mammals, contributing to better health outcomes in veterinary medicine.
Collaborations
Kenneth collaborates with esteemed colleagues such as Bengt Guss and Jan-Ingmar Flock. Their combined expertise enhances the research and development efforts at Intervacc AB, where Kenneth is employed.
Conclusion
Kenneth Janzon is a dedicated inventor whose work in antigenic compositions and vaccine development is paving the way for advancements in immunization. His contributions are vital to the field and hold promise for future innovations in veterinary medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile